The table below shows Edwards Lifesciences Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Revenue
$1.65B
$1.55B
$1.53B
$1.41B
$1.39B
$1.35B
Cost of revenue
$362.60M
$345.20M
$344.40M
$301.60M
-
$262.90M
Gross profit
$1.29B
$1.21B
$1.19B
$1.11B
$1.09B
$1.09B
R&D
$263.30M
$280.70M
$276.20M
$254.60M
-
$253.40M
EW annual revenue (10-K history)
Edwards Lifesciences Corp reported annual revenue of $6.07B for fiscal year 2025. That is up 11.5% from $5.44B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $2.96B (FY 2016) to $6.07B. Figures come from the company's audited annual reports as filed with the SEC.
